Selected article for: "infection duration and pre peak phase"

Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
  • Document date: 2020_4_14
  • ID: d7stppv5_103
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . Fig S4. Treatment projections of hydroxychloroquine assuming different potency and timing of treatment. Each set of simulations is performed under assumptions of high, medium and low potency. Treatment initiation is at timepoints generally consistent with a. hospitalization (day 10 after first positive sample), b. first symptoms (day 5 after first positive sample), c. p.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . Fig S4. Treatment projections of hydroxychloroquine assuming different potency and timing of treatment. Each set of simulations is performed under assumptions of high, medium and low potency. Treatment initiation is at timepoints generally consistent with a. hospitalization (day 10 after first positive sample), b. first symptoms (day 5 after first positive sample), c. presymptomatic post-peak phase (day 2 after first positive sample) and d. pre-symptomatic pre-peak phase (day 0). Overall, early potent treatment limits duration of infection. Heatmaps comparing variance in drug potency measured by in vivo EC50 (x-axis) and timing of treatment initiation (y-axis) for e. Shedding duration, f. viral load area under the curve (AUC) and g. extent of T cell response required for viral elimination.

    Search related documents:
    Co phrase search for related documents
    • AUC curve and drug potency: 1
    • AUC curve and early potent treatment: 1
    • AUC curve and infection duration: 1, 2, 3, 4
    • AUC curve and low medium high potency: 1
    • AUC curve and positive sample: 1
    • AUC curve and positive sample 10 day: 1
    • AUC curve and positive sample 10 day hospitalization: 1
    • AUC curve and pre peak phase: 1
    • AUC curve and Shedding duration: 1, 2, 3, 4, 5, 6
    • AUC curve viral load area and cell response: 1, 2
    • AUC curve viral load area and drug potency: 1
    • AUC curve viral load area and early potent treatment: 1
    • AUC curve viral load area and infection duration: 1, 2, 3
    • AUC curve viral load area and low medium high potency: 1
    • AUC curve viral load area and positive sample: 1
    • AUC curve viral load area and positive sample 10 day: 1
    • AUC curve viral load area and positive sample 10 day hospitalization: 1
    • AUC curve viral load area and pre peak phase: 1
    • AUC curve viral load area and Shedding duration: 1, 2, 3